BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21145195)

  • 1. Effectiveness of ultrasound-guided radiofrequency ablation in the treatment of 36 renal cell carcinoma tumours compared with published results of using computed tomography guidance.
    Davis K; Kielar A; Jafari K
    Can Assoc Radiol J; 2012 Aug; 63(3 Suppl):S23-32. PubMed ID: 21145195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.
    Iannuccilli JD; Dupuy DE; Beland MD; Machan JT; Golijanin DJ; Mayo-Smith WW
    Eur Radiol; 2016 Jun; 26(6):1656-64. PubMed ID: 26373755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of General Anesthesia and Conscious Sedation During Computed Tomography-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma.
    Kim HJ; Park BK; Chung IS
    Can Assoc Radiol J; 2018 Feb; 69(1):24-29. PubMed ID: 29198818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
    Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
    Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
    Kim HJ; Park BK; Park JJ; Kim CK
    Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients.
    Balageas P; Cornelis F; Le Bras Y; Hubrecht R; Bernhard JC; Ferrière JM; Ravaud A; Grenier N
    Eur Radiol; 2013 Jul; 23(7):1925-32. PubMed ID: 23443351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
    Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
    AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
    Duan XH; Li YS; Han XW; Wang YL; Jiao DC; Li TF; Chen PF; Fang Y
    Clin Radiol; 2016 Jan; 71(1):79-85. PubMed ID: 26602936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
    De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U
    Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment imaging can be used to select imaging guidance, ultrasound alone versus CT plus ultrasound, for percutaneous renal radiofrequency ablation.
    McGahan JP; Loh S; Fitzgerald E; Koppie T; Evans CP; Dall'Era M; Li CS
    AJR Am J Roentgenol; 2011 Nov; 197(5):1244-50. PubMed ID: 22021521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous RF thermal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques?
    Veltri A; Garetto I; Pagano E; Tosetti I; Sacchetto P; Fava C
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):76-85. PubMed ID: 18709413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
    Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
    J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
    Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
    Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
    Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
    AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
    Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic radiofrequency under CT-fluoroscopy guidance.
    Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C
    Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
    Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
    Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.